Anzeige
Mehr »
Samstag, 07.02.2026 - Börsentäglich über 12.000 News
Der Shakeout: Silber hat genau das getan, was echte Bullenmärkte immer tun - es hat die Touristen abgeschüttelt
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3CS50 | ISIN: BE0974386188 | Ticker-Symbol: 86C
Frankfurt
06.02.26 | 08:17
2,950 Euro
-0,67 % -0,020
Branche
Chemie
Aktienmarkt
Sonstige
1-Jahres-Chart
BIOTALYS NV Chart 1 Jahr
5-Tage-Chart
BIOTALYS NV 5-Tage-Chart
RealtimeGeldBriefZeit
3,0103,09013:04
3,0303,07006.02.

Aktuelle News zur BIOTALYS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
23.01.Biotalys NV: Biotalys and 21st.BIO Enter into Strategic Partnership to Advance Biocontrol Production384Biotalys Provides Update on Its Plans to Fund Next Phase of DevelopmentGhent, BELGIUM, Jan. 23, 2026 (GLOBE NEWSWIRE) -- Press release - inside information* Biotalys) and 21st.BIO, a leading Danish...
► Artikel lesen
02.12.25Biotalys Secures EPA Approval For EVOCA, First Protein-Based Biofungicide2
02.12.25Biotalys NV: Biotalys Receives Regulatory Approval by U.S. EPA for EVOCA556U.S. Registration Marks a Significant Milestone as the First Protein-Based Biofungicide of its Kind to be Approved by the EPAGhent, BELGIUM, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Press release - inside...
► Artikel lesen
03.11.25XFRA 86C: WIEDERAUFNAHME/RESUMPTION287FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME...
► Artikel lesen
31.10.25Biotalys shares jump as EPA proposes registration of first biofungicide3
31.10.25Biotalys NV: EPA Issues Proposed Registration Decision for Biotalys' EVOCA Biofungicide495U.S. Environmental Protection Agency Initiates Public Participation ProcedureGhent, Belgium, Oct. 31, 2025 (GLOBE NEWSWIRE) -- Press release - inside information EPA Issues Proposed Registration...
► Artikel lesen
BIOTALYS Aktie jetzt für 0€ handeln
30.10.25XFRA 86C: AUSSETZUNG/SUSPENSION301DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILBIOTALYS NV 86C...
► Artikel lesen
20.10.25Biotalys NV: Regulated information392Information on the total number of voting rights and sharesGhent, Belgium, Oct. 20, 2025(hereafter the "Company" or "Biotalys") today announces, in accordance with article 15 of the Belgian Act of 2...
► Artikel lesen
18.09.25Biotalys NV H1 Loss Climbs2
18.09.25Biotalys NV: Biotalys Reports Half-Year 2025 Financial Results and Business Highlights561Press release - regulated informationGhent, Belgium, Sept. 18, 2025 (GLOBE NEWSWIRE) -- Substantial progress in both the U.S. and Europe in the regulatory review of Biotalys' first candidate...
► Artikel lesen
29.08.25Biotalys NV: Biotalys Provides Regulatory Review Update for EVOCA in the U.S.496Inside informationGhent, BELGIUM, Aug. 29, 2025) today provides an update on the regulatory approval procedure in the United States of its first protein-based biocontrol product, EVOCA*. Biotalys...
► Artikel lesen
30.07.25Biotalys NV: Information on the total number of voting rights and shares483Press Release - Regulated InformationGhent, BELGIUM, July 30, 2025(hereafter the "Company" or "Biotalys"), an Agricultural Technology (AgTech) company developing protein-based biocontrol solutions for...
► Artikel lesen
16.06.25Biotalys NV: Publication of transparency notification576Article 14(1) of the Law of 2 May 2007 on the disclosure of large shareholders in issuers whose shares are admitted to trading on a regulated marketGhent, BELGIUM, June 16, 2025 (GLOBE NEWSWIRE) --...
► Artikel lesen
11.06.25Biotalys NV: Biotalys Reports Progress in the Regulatory Review of EVOCA in both US and EU651US EPA projects taking a regulatory decision by end of September 2025; Dutch authorities finalise first phase of regulatory dossier for EVOCA in Europe Ghent, BELGIUM, June 11, 2025 (GLOBE NEWSWIRE)...
► Artikel lesen
26.05.25Biotalys NV: Biotalys Appoints Luc Van fraeyenhoven as Chief Financial Officer547Seasoned Financial Executive Will Lead Finance Operations as Biotalys Pushes Product Pipeline Toward Commercialization Ghent, May 26, 2025 (GLOBE NEWSWIRE) -- Press release Ghent, BELGIUM - 26...
► Artikel lesen
20.05.25Biotalys NV: Biotalys and AgroFresh Partner to Protect Fresh Produce479Global leaders in sustainable agricultural innovation to develop biological solutions to reduce food wasteGhent, BELGIUM, and Philadelphia, USA, May 20, 2025 (GLOBE NEWSWIRE) -- Press release Ghent...
► Artikel lesen
22.04.25Biotalys NV: Results of the Ordinary Shareholders' Meeting374Regulated InformationGhent, Belgium, April 22, 2025)of the Company. The minutes will be made available in due course. For further information, please contact:Toon Musschoot, Head of Investor Relations...
► Artikel lesen
25.03.25Biotalys NV: Biotalys to Appoint Toni Bucci to its Board of Directors951Seasoned Agriculture and Biotech Executive With a Passion to Feed the World SustainablyGhent, BELGIUM, March 25, 2025 (GLOBE NEWSWIRE) -- Press release Biotalys), an Agricultural Technology (AgTech)...
► Artikel lesen
21.03.25Biotalys NV: Invitation to the ordinary general shareholders meeting624Ghent, BELGIUM, March 21, 2025 (GLOBE NEWSWIRE) -- Press release - regulated information Biotalys(the "Company" or "Biotalys"), an Agricultural Technology (AgTech) company developing protein-based...
► Artikel lesen
19.03.25Biotalys NV: Biotalys Reports Full-Year 2024 Financial Results and Business Highlights892Ghent, BELGIUM, March 19, 2025 (GLOBE NEWSWIRE) -- Press release - regulated information Continued to work closely with European and U.S. regulators on the regulatory review of its first candidate...
► Artikel lesen
Weiter >>
21 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1